An open label, randomized Phase II study of BI 754091 alone or in combination with BI 836880 in patients with chemotherapy resistant, unresectable, metastatic squamous cell carcinoma of the anal cancer

  • Segelov, Eva (Primary Chief Investigator (PCI))

Project: Research

Project Details

StatusFinished
Effective start/end date21/08/20 → 19/10/20

Keywords

  • clinical trial
  • anal cancer
  • treatment efficacy